We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer’s Yasmin Patent Invalid for Obviousness
Bayer’s Yasmin Patent Invalid for Obviousness
March 18, 2008
A federal district court has found Bayer Schering Pharma’s ’531 patent on the oral contraceptive Yasmin invalid due to obviousness as a result of a challenge from Barr Laboratories.